Anti-TNF agents for paediatric psoriasis-Reference-Cited by-同舟云学术

Anti-TNF agents for paediatric psoriasis

Published:2015-11-24 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sanclemente Gloria¹,Murphy Ruth²³,Contreras Javier⁴,García Hermenegildo⁵,Bonfill Cosp Xavier⁶

Affiliation:

1. Universidad de Antioquia; Grupo de Investigación Dermatológica (GRID); Carrera 25 A #1 A Sur 45, Of 2026 Torre Medica El Tesoro Medellín Colombia

2. Sheffield Children's NHS Foundation Trust; Department of Dermatology, Sheffield Children's Hospital; Sheffield UK S10 2JF

3. Sheffield Teaching Hospitals NHS Foundation Trust; Department of Dermatology; Sheffield UK

4. Universidad de Antioquia; Department of Pediatrics, School of Medicine; Carrera 51d Nº 62-29 Facultad de Medicina Medellin Antioquia Colombia 050010

5. The University of Nottingham; c/o Cochrane Skin Group; A103, King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR

6. CIBER Epidemiología y Salud Pública (CIBERESP); Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 167 Pavilion 18 Barcelona Catalunya Spain 08025

Publisher

Wiley

Subject

Pharmacology (medical)

Reference90 articles.

1. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis;Landells;European Journal of Dermatology,2010

2. Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial;Langley;Journal of the American Academy of Dermatology,2011

3. Etanercept in children and adolescents with psoriasis (ABP08-119);Levy;Journal of the European Academy of Dermatology & Venereology,2005

4. Safety and efficacy of etanercept treatment in children and adolescents with plaque psoriasis: 96-week results of open-label extension study;Paller;Journal of the American Academy of Dermatology,2010

5. A 12 week phase 3 study of efficacy and safety of etanercept therapy in children and adolescents with moderate to severe plaque psoriasis;Paller;Journal of the American Academy of Dermatology,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology and molecular docking to explore the mechanism of a clinical proved recipe for external use of clearing heat and removing dampness in the treatment of immune-related cutaneous adverse events;Medicine;2024-03-15

2. Paradoxical Psoriasiform Eruptions in Children Receiving Tumor Necrosis Factor α Inhibitors;JAMA Dermatology;2023-06-01

3. Treatment algorithms for special cases;TURKDERM;2022-05-05

4. Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis;Experimental Dermatology;2021-11-26

5. Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients;Expert Review of Clinical Immunology;2021-07-30